Press Releases

    The CEO Roundtable on Cancer Salutes Coach Mike Krzyzewski

    2015-01-26T00:00:00-06:00January 26, 2015|

    The CEO Roundtable on Cancer salutes Coach Mike Krzyzewski on his 1000th victory, further solidifying his legacy as the winningest men's basketball coach in NCAA Division I history. In addition to his recent history-making win, Coach K’s trailblazing resume includes leading the U.S. men's national basketball team to gold medals at the 2008 and 2012 Summer Olympics and the 2010 and 2014 FIBA World Championships and serving as assistant coach for the Olympic gold medal-winning “Dream Team” in 1992.

    Celgene Corporation Earns Global CEO Cancer Gold Standard Accreditation

    2014-12-18T00:00:00-06:00December 18, 2014|

    CARY, NC (December 18, 2014) Celgene Corporation, a global biopharmaceutical company headquartered in Summit, New Jersey, has earned the prestigious global CEO Cancer Gold StandardTM accreditation. This accreditation recognizes the Company’s worldwide commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring broad access to innovative cancer therapies that are extending lives, improving quality of life and increasing productivity for employees and their family members around the globe.

    AstraZeneca and Memorial Sloan Kettering Cancer Center Receive the CEO Roundtable on Cancer’s Dr. Charles A. Sanders Life Sciences Awards

    2014-11-11T00:00:00-06:00November 11, 2014|

    CARY, NC (November 11, 2014) – The CEO Roundtable on Cancer presented AstraZeneca and Memorial Sloan Kettering Cancer Center with the 2014 Dr. Charles A. Sanders Life Sciences Awards in recognition of their innovative and collaborative work on Project Data Sphere, LLC, an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium.

    Amgen Receives CEO Cancer Gold Standard Accreditation

    2014-08-11T00:00:00-05:00August 11, 2014|

    CARY, N.C. (August 11, 2014) – The CEO Roundtable on Cancer today announced that Amgen, Inc., one of the world's leading biotechnology companies, has received CEO Cancer Gold Standard™ accreditation. This achievement recognizes employers’ commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for employees and covered family members.

    The CEO Roundtable on Cancer joins Worldwide Innovative Networking (WIN) Consortium for personalized cancer medicine

    2014-06-26T00:00:00-05:00June 26, 2014|

    CARY, NC (June 26, 2014) – At the fourth annual Worldwide Innovative Networking (WIN) Consortium in personalized cancer medicine, it was announced that the CEO Roundtable on Cancer has accepted membership in this global cancer research collaborative, joining stakeholders from North and South America, Europe, Asia, and the Middle East seeking to address the challenge of increasing the efficacy of genetically-targeted cancer diagnostics and therapeutics.

    The CEO Roundtable on Cancer Honored with Project HOPE’s Global Health Impact Award

    2014-06-11T00:00:00-05:00June 11, 2014|

    CARY, NC (June 11, 2014) – At its annual Gala held at the Mellon Auditorium in Washington, DC, Project HOPE presented its 2014 Global Health Impact Award to the CEO Roundtable on Cancer. The Global Health Impact Award provides Project HOPE with the opportunity to honor a peer non-profit organization achieving significant advances in global health. In addition to its ongoing, global, workplace health and wellness efforts through its CEO Cancer Gold Standard accreditation program, Project HOPE noted the leadership of the CEO Roundtable in promoting much-needed sharing of critical clinical trial data in oncology.

    Carroll Hospital Center Receives CEO Cancer Gold Standard Accreditation

    2014-05-19T00:00:00-05:00May 19, 2014|

    CARY, NC (May 19, 2014) Carroll Hospital Center in Westminster, MD is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. The CEO Roundtable on Cancer has accredited Carroll Hospital Center with the CEO Cancer Gold Standard recognizing their efforts to reduce the risk of cancer for its employees and covered family members.

    CEO Roundtable on Cancer Launches the Project Data Sphere Initiative, A New Data Sharing and Analytic Platform for Cancer Patient Benefit

    2014-04-08T00:00:00-05:00April 8, 2014|

    CARY, NC (April 8, 2014) – Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), announced today the launch of a new data sharing platform (www.ProjectDataSphere.org), with the goal of advancing research to improve the lives of cancer patients and their families around the world. The CEO Roundtable on Cancer was established in 2001 with the mandate to bring bold and imaginative solutions to cancer care.

    Bayer Healthcare Receives CEO Cancer Gold Standard Accreditation

    2014-03-18T00:00:00-05:00March 18, 2014|

    CARY, NC (March 18, 2014) – Bayer HealthCare is leading by example when it comes to promoting healthy lifestyle choices and encouraging workplace wellness. The CEO Roundtable on Cancer has accredited Bayer HealthCare’s new U.S. headquarters site in Whippany, N.J., with the CEO Cancer Gold StandardTM recognizing the firm’s efforts to reduce the risk of cancer for its employees and covered family members by establishing programs to reduce cancer risk, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

    Putnam Hospital Center Receives CEO Cancer Gold Standard Accreditation

    2014-02-03T00:00:00-06:00February 3, 2014|

    CARY, NC (February 3, 2014) – Putnam Hospital Center in Carmel, NY, is leading by example when it comes to promoting healthy lifestyle choices and encouraging workplace wellness. The CEO Roundtable on Cancer has accredited Putnam Hospital Center with the CEO Cancer Gold StandardTM recognizing the firm’s efforts to reduce the risk of cancer for its employees and covered family members by establishing programs to reduce cancer risk, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

    Go to Top